The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label

Wang Y.-H.Chen C.-B.Tassaneeyakul W.Saito Y.Aihara M.Choon S.E.Lee H.Y.Chang M.M.Roa F.D.Wu C.-W.Zhang J.Nakkam N.Konyoung P.Okamoto-Uchida Y.Cheung C.M.-T.Huang J.-W.Ji C.Cheng B.Hui R.C.-Y.CHIA-YU CHUChen Y.-J.Wu C.-Y.Hsu C.-K.Chiu T.-M.Huang Y.-H.Lu C.-W.Yang C.-Y.Lin Y.-T.Chi M.-H.Ho H.-C.Lin J.-Y.Yang C.-H.Chang Y.-C.Su S.-C.Wang C.W.Fan W.-L.Hung S.-I.Chung W.-H.for the Asian Severe Cutaneous Adverse Reaction Consortium2019-12-042019-12-0420190009-9236https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052614824&doi=10.1002%2fcpt.1071&partnerID=40&md5=690abe5b075615a1d07965b1388a616ehttps://scholars.lib.ntu.edu.tw/handle/123456789/434865The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Labeljournal article10.1002/cpt.1071295697402-s2.0-85052614824